Introduction
Apoptosis is a major cellular response to stress. One important source of stress is lack of extracellular signals, both soluble and emanating from extracellular matrix or cell to cell interactions. Competition for limiting survival signals appears to be the basis for maintaining constant numbers of cells in dierent tissues under normal, non-pathological, conditions (Ra, 1992) . Deregulation of the carefully maintained balance between survival and cell death leads to pathologies such as cancer or degenerative diseases (reviewed in Thompson, 1995) . An important pathway activated in response to extracellular factors involves PI(3)K and Akt and signals survival in many cell types (reviewed in . All the details of this pathway have not yet been elucidated, although several Akt substrates have been shown to favour survival upon their phosphorylation (Brunet et al., 1999; Cardone et al., 1998; Ozes et al., 1999; Romashkova and Makarov, 1999) .
PI(3)K can be activated directly by ligand bound surface receptors or indirectly by activated Ras (reviewed by Carpenter and Cantley, 1996) . The small GTPase Ras plays a pivotal role in transducing proliferative, survival but also apoptotic signals (recently reviewed in Downward, 1998) . The multifunctionality of Ras is, at least in part, achieved through interactions with its dierent eectors and, as all major cellular responses, depends on the precise physiological context of the cell. In addition to activating the PI(3)K/Akt pathway, Ras can also signal survival by activating NF-kB (Mayo et al., 1997) . Activation of the proliferative cascade through Raf, MEK and MAP kinases ERK1 and 2 has also in some cases been associated with cellular survival (Xia et al., 1995) . However, in dierent cell types and possibly under dierent physiological conditions ERK activation causes apoptosis rather than survival (Goillot et al., 1997; Jimenez et al., 1997; Kauman-Zeh et al., 1997) .
The Rho proteins, which delineate another subgroup of the Ras superfamily, might also be critical regulators of apoptotic pathways. These proteins, which include Rac1, RhoA, Cdc42Hs and RhoG, have long been implicated in many physiological processes such as the control of cell shape, motility, polarity, adhesion and division (reviewed in Hall, 1998) . All these events involve morphological changes associated with actin polymerization. In addition to their role in cell morphology, Rho proteins are involved in normal and pathological cell proliferation (reviewed in Fort, 1999) . Constitutively active RhoA, Rac1 or Cdc42Hs trigger entry of quiescent ®broblasts into S phase and promote the activation of the serum response factor (SRF), a transcription factor that controls the expression of many growth factor-regulated genes. Rho members also participate in Ras-mediated transformation and delineate distinct pathways that cooperate to transform NIH3T3 cells. Several lines of evidence suggest that Rho proteins are also directly implicated in the control of apoptosis: RhoA promotes apoptosis of NIH3T3 cells through ceramide production, and activity of RhoA, Rac1 and Cdc42Hs proteins is required for Fas ligand-mediated apoptosis in T cells. Similarly, mice harbouring a transgene encoding the constitutively activated Rac GTPase, whose expression is targeted to early T lymphocyte precursors, suer severe thymic atrophy due to elevated thymocyte apoptosis. It has also been reported that the constitutively active mutant of Cdc42Hs (Cdc42HsV12) induces apoptosis in the human leukaemic Jurkat T cells (Chuang et al., 1997) . The molecular mechanisms of apoptosis induction by the activated forms of these GTPases are unknown. It has been shown that in many cases, apoptosis correlates with the stimulation of the stress activated MAP kinases SAPK/ JNK and p38 (reviewed in Schulze-Ostho et al., 1998) , which are downstream targets of Cdc42Hs and Rac1 (Coso et al., 1995; Minden et al., 1994) . However, numerous cases of apoptosis occurring independently of JNK activation have also been described (Khwaja and Lenczowski et al., 1997; Liu et al., 1996) .
Another protein with a major role in the cellular response to stress is the p53 tumour suppressor. p53 is present in normal cells at a low basal level. It is stabilized and activated in response to dierent stresses (Giaccia and Kastan, 1998), but not in response to lack of extracellular factors (Lassus et al., 1996) . Upon activation, p53 can lead to two major cellular responses: cell cycle arrest or apoptosis. The molecular mechanisms of cell cycle arrest by p53 have been extensively studied, and are strictly dependent on the transactivation of p53 target genes. The mechanisms of apoptosis induction are less well understood. It would appear that p53 can induce apoptosis both via the transcriptional control of its target genes as well as through, as yet poorly de®ned, non-transcriptional mechanism (reviewed in Hansen and Oren, 1997; Ko and Prives, 1996; Levine, 1997) .
Since both small GTPases of the Rho family and p53 are implicated in the response to cellular stress and, as a consequence, in the regulation of apoptosis, we set out to investigate the links between these two signalling pathways. Here we report that forced expression of constitutively active forms of Rac1 and Cdc42Hs rescues ®broblasts from apoptosis induced by detachment from extracellular matrix. Conversely, dominant negative mutants of these GTPases induce apoptosis of adherent ®broblasts. Wild type p53 and extracellular signal activated kinases (ERKs) appear to be necessary for this pathway of cell death induction. Our results demonstrate the existence of a complex set of functional interactions between GTPases of the Rho family, p53 and ERKs, participating in the control of apoptosis.
Results
Activated Rac1 and Cdc42Hs signal survival in non-adherent Balb/C 3T3 fibroblasts Survival of adherent cells is conditioned by signals from the environment. The intracellular signalling pathways leading from adhesion and resulting in the cell's survival are largely unknown. However, Cdc42Hs and Rac1, two small GTPases of the Rho family, are likely to play a role in this signal transduction. We wished to determine if ®broblasts cultured in suspension could be rescued from apoptosis by forced activation of these GTPases.
Balb/C 3T3 murine ®broblasts were put in suspension by culturing over a layer of agarose in a culture dish. This treatment resulted in massive cell death, with nearly 50% of the cells dying within 24 h (Figure 1) . In order to test the role of Cdc42Hs and Rac1 signalling in this process we have infected the cells with recombinant viruses encoding the constitutively active forms of the GTPases (V12 mutants). The infected cells were selected by growth in the presence of puromycin for 4 days and then put in suspension. Constitutive activation of Cdc42Hs signalling dramatically increased the viability of cells cultured in suspension, since only about 15% of cells died after 24 h of this treatment. The forced expression of Rac1V12 mutant also resulted in signi®cant rescue, with nearly 30% of cells dead at the end of the experiment shown. The observed cell death was apoptosis, as judged by DNA fragmentation assayed by the TUNEL method (Gavrieli et al., 1992) , nuclear morphology changes and Annexin V labelling, a method that detects early apoptotic as well as necrotic cells (Martin et al., 1995) (data not shown).
Inhibition of Rac1 or Cdc42Hs signals apoptosis in adherent Balb/C 3T3 fibroblasts
We reasoned that since the constitutively active forms of Cdc42Hs and Rac1 rescued non-adherent ®bro-blasts, forced expression of dominant negative mutants of these GTPases might cause apoptosis in adherent cells. We ®rst attempted to produce ®broblast cell lines expressing dominant negative forms of either Cdc42Hs or Rac1. No stable cell lines could be established for either construct, suggesting that the proteins were toxic to the cells (data not shown).
To further examine this eect, constitutively active (V12) or dominant negative (N17) mutants of Rac1 and Cdc42Hs GTPases were transiently transfected into murine Balb/C 3T3 ®broblasts. In order to analyse the transfected sub-populations, a plasmid encoding a truncated form of rat CD2 antigen, lacking the intracytoplasmic domain, was co-transfected with the mutant GTPases. The expression levels of dierent constructs, veri®ed by Western blot, were comparable (not shown). The fate of transfected cells was analysed by¯ow cytometry after Annexin V labelling ( Figure  2a ). The expression of the V12 forms of either Rac1 or Cdc42Hs gave rise to little apparent toxicity above background (510% dead cells), while the expression of the N17 mutant of either protein resulted in close to 30% of Annexin V positive cells.
To con®rm that Annexin V labelling corresponded to apoptotic cells we used two additional criteria, namely nuclear morphology changes and DNA fragmentation. Figure 2b illustrates that expression of the dominant negative form of Rac1 and Cdc42Hs GTPases gave rise to cells with condensed chromatin, while in the control population transfected with the empty vector cells did not display the apoptotic nuclear morphology. DNA fragmentation was assayed by the TUNEL method. As shown in Figure 2c , expression of the Rac1N17 or Cdc42HsN17 fused to GFP led to more than 35% of TUNEL-positive green¯uorescent cells, a number comparable to the Annexin V positive cells detected under similar conditions. As a control, expression of GFP alone gave rise to the background of 4% TUNEL positive cells.
To con®rm that Cdc42HsN17-dependent apoptosis induction was a direct consequence of the inhibition of Cdc42Hs activity, we transfected Balb/C 3T3 cells with a construct expressing the Cdc42Hs-interacting domain of the Wiskott-Aldrich syndrome protein (WASP), a speci®c eector for Cdc42Hs involved in actin polymerization (Aspenstrom et al., 1996; Symons et al., 1996) . This fragment inhibits the endogenous Cdc42Hs activity through competition with its eector binding site. As shown in Figure 2d , expression of the WASP fragment elicited apoptosis at least as eciently as Cdc42HsN17 mutant protein, thereby demonstrating that inhibition of Cdc42Hs activity directly triggers apoptosis in Balb/C 3T3 cells.
Apoptosis induction by Rac1N17 and Cdc42HsN17 requires p53
Many apoptotic signalling pathways depend on the presence of functional p53 tumour suppressor (Evan and Littlewood, 1998) . To address the possibility that p53 might be associated with the Rac1N17 and Cdc42HsN17-dependent pathway leading to apoptosis, we used the 10.1 cell line which derives from the same genetic background as Balb/C 3T3 ®broblasts but is deleted of both p53 alleles (Harvey and Levine, 1991) . We ®rst compared the eects of the expression of the dominant negative and constitutively active mutants of Rac1 and Cdc42Hs in both cell lines (Figure 3a) . Expression of either N17 or V12 mutants of Cdc42Hs and Rac1 GTPases elicited no apoptotic phenotype in p53 7 cells, whereas, as described above, forced expression of the N17 mutants of either GTPase induced a dramatic apoptotic response in p53 + cells. In order to con®rm the role of p53, we analysed the eects of Rac1N17 and Cdc42HsN17 in 10.1 cells complemented by the human wild type p53 protein. In agreement with data presented in Figure 3a , p53 alone or dominant negative GTPases did not eciently induce apoptosis in 10.1 cells. The complementation of p53 7 cells by wild type p53 restored a strong apoptotic response to both Cdc42Hs ( Figure 3b ) and Rac1 (Figure 3c ) dominant negative mutants. We also examined the ability of two naturally occurring p53 mutants, namely p53H175 and p53H273, to complement the induction of apoptosis in ) cells were transfected with Cdc42HsN17 (b) or Rac1 N17 (c) expressing plasmids, either alone or in combination with plasmids expressing p53wt or dominant negative p53 mutants (p53H273 or p53H175). Apoptosis of transfected cells was assayed as in Figure 2a . The mean values and the range of variation from two independent experiments are shown 10.1 cells. Both mutations map to the DNA binding domain of p53 and result in the loss of the sequence speci®c DNA binding activity (Ory et al., 1994) . The mutant proteins induce neither cell cycle arrest nor apoptosis and have a dominant negative phenotype on p53 (Kern et al., 1992; Ory et al., 1994) . As shown in Figure 3 (b,c) , the mutants failed to restore the apoptotic response to the 10.1 cells, leading to the conclusion that active p53 is required for the apoptotic response triggered by Cdc42HsN17 and Rac1N17.
p53 is required for apoptosis of primary fibroblasts grown in suspension Induction of apoptosis by the dominant negative mutants of Cdc42Hs and Rac1 was next tested on early passage primary mouse ®broblasts (MEFs) from p53 +/+ and p53 7/7 backgrounds. Results in Figure 4a demonstrate that inhibition of Cdc42Hs and Rac1 signalling induces p53-dependent apoptosis in primary cells. We next investigated implication of p53 in apoptosis of primary cells kept in suspension culture. To this end, p53 +/+ and p53 7/7 MEFs were plated over a layer of agarose and kept in suspension culture for 16 h. Data presented in Figure 4b show that p53 +/+ cells were highly sensitive to this treatment with over 50% of the cells dead at the end of the experiment. The p53 7/7 cells were signi®cantly more resistant to death induced by lack of attachment to the substratum.
Dominant negative forms of Rac1 and Cdc42Hs activate endogenous p53 in primary fibroblasts
We wished to determine whether mutant Rac1 and Cdc42Hs proteins might modulate the activity of the endogenous p53 protein. To this aim, we have performed transient transfections of MEF cells with vectors encoding GFP fused to Rac1N17 and Cdc42HsN17 proteins, previously assayed for maintaining the biological activity of the mutants (data not shown). Transfections of GFP and wild type p53 served as negative and positive controls, respectively. Figure 5 shows the results of immuno¯uorescence analysis of nuclear accumulation of the endogenous p53 (left panel) and one of its targets, the mdm2 protein (right panel). Control, GFP transfected cells, show no accumulation of either p53 or mdm2 while in p53 transfected cells both p53 and mdm2 are easily detectable. Similarly, cells expressing the dominant negative forms of Rac1 and Cdc42Hs show nuclear accumulation of both p53 and mdm2.
From these experiments, we conclude that ectopic expression of the dominant negative forms of Rac1 and Cdc42Hs activate endogenous p53. However, p53 activation by itself does not cause apoptosis in either immortalized or primary ®broblasts (Lassus et al., 1996) . We therefore analysed other signalling pathways induced by the N17 forms of the GTPases which could constitute a co-stimulus for apoptosis induction.
ERK activity is required for apoptosis induced by inhibition of Cdc42Hs or Rac1 signalling
The activated forms of Cdc42Hs and Rac1 activate stress kinases JNK and p38 (Coso et al., 1995; Minden et al., 1994) . In order to determine if these MAP kinases are implicated in the control of apoptosis by the Rho family GTPases we tested the eect of inhibition of p38 MAPK on apoptosis of ®broblasts in suspension culture. Primary mouse ®broblasts infected with retroviral vectors encoding either GFP, GFP fused to Rac1V12 or Cdc42HsV12 mutants were plated over a layer of agarose in the presence or absence of SB-203580, a speci®c inhibitor of p38 MAPK (Cuenda et al., 1995) . Cell death was assayed by Trypan Blue exclusion. As described above and shown in Figure 6a , forced expression of the constitutively active GTPases rescues suspended cells from apoptosis. Inhibition of p38 MAPK has no eect on apoptosis of the control cells but it inhibits the rescue by the activated forms of Rac1 and Cdc42Hs.
We next investigated the role of MAP kinases in apoptosis induced in adherent ®broblasts by mutants of Cdc42Hs and Rac1. To this end, Balb/C 3T3 cells were transiently transfected with the constructs expressing either the constitutively active or the dominant negative forms of the GTPases and treated with either SB-203580 or PD-098059, a speci®c inhibitor of MEK1, the kinase which phosphorylates and activates ERK (Dudley et al., 1995) . The proportion of apoptotic cells in the transfected populations was then assayed by Annexin V labelling ( Figure 6b ). As described above, the activated form of the GTPases In agreement with the data presented in Figure 6a , inhibition of MAPK p38 revealed the apoptotic response in the ®broblasts expressing the activated forms of Cdc42Hs or Rac1. The same treatment had no eect on apoptosis induced by the dominant negative forms of the GTPases. On the other hand, inhibition of ERK by PD-098059 had no eect on Rac1V12 or Cdc42HsV12 expressors, but totally abolished Rac1N17-and Cdc42HsN17-induced apoptosis. The ability of both drugs to eciently inhibit their cognate kinase targets was controlled by in vitro kinase assays (data not shown).
We have further studied the role of ERK in the apoptosis induced by cell detachment from the substratum. As shown in Figure 6c , inhibition of MEK1 by PD-098059 signi®cantly improves the survival of ®broblasts kept in suspension culture. Since we have shown that these culture conditions lead to apoptosis which can be inhibited by constitutively active forms of either Cdc42Hs or Rac1, it would appear that in our experimental system, apoptosis due to the loss of Cdc42Hs or Rac1 signalling upon loss of adhesion depends on MAPK ERK activity while the rescue provided by the activated forms of the GTPases requires MAPK p38 signalling.
Discussion
Apoptosis represents a biological process that under normal physiological conditions allows an organism to eliminate cells. This is controlled through ®ne-tuned mechanisms by which cell-speci®c interactions of surface receptors with their cognate ligands induce cell death or survival. Numerous signalling pathways leading to apoptosis have been described in many cell types (recently reviewed in Ashkenazi and Dixit, 1998; Evan and Littlewood, 1998) . However, these signalling pathways appear to converge towards a reduced number of regulatory proteins, among which p53 and GTPases of the Ras superfamily have been identi®ed. We report here that inhibition of Rac1 or Cdc42Hs, two GTPases of the Rho family, elicits a rapid and dramatic p53-dependent and ERK-dependent apoptotic response in murine ®broblasts. In addition, inhibition of Rac1 and Cdc42Hs is associated with an increase in p53 activity.
Members of the Rho family of small GTPases have long been known to play a key role in transducing signals that lead to cell proliferation, reshaping and motility (reviewed in Hall, 1998) . More recently, it has been demonstrated that these proteins are also implicated in apoptosis control (Bazenet et al., 1998; Chuang et al., 1997; Donovan et al., 1997; Fort, 1999 and references therein) . Whereas these studies report a role for activated Rho, Rac and Cdc42Hs in apoptosis regulation, we show here that expression of the dominant negative forms of Rac1 and Cdc42Hs are also potent inducers of apoptosis. These dominant negative proteins, which harbour a substitution at position 17 from threonine to asparagine, have decreased anity for GTP versus GDP (Feig and Cooper, 1988) . Their inhibitory eect is thought to result from competitive interactions with the exchange factors (GEFs) that activate the corresponding endogenous GTPase, thereby preventing the normal activation of downstream targets. In addition, it has been reported that GDP-bound GTPases can also activate speci®c targets (Park et al., 1997) . Thus, the use of N17 mutants might inhibit the signals emanating from the GTP-bound state and constitutively activate those emanating from the GDP-bound state. This latter possibility was addressed by expressing a WASP fragment that binds only to GTP-bound Cdc42Hs and inhibits its activity through competitive binding to the eector site (Aspenstrom et al., 1996; Symons et al., 1996) . The ecient induction of apoptosis observed upon blocking the Cdc42Hs signalling by the WASP fragment strongly suggests that the eect is a direct consequence of the loss of the endogenous GTP-bound GTPase activity. An analogous situation has been reported for EL4 T lymphoma cells, in which inactivation of RhoA promotes multinucleate cell formation and apoptosis (Moorman et al., 1996) . We have also shown that apoptosis induced by detachment of cells from culture dish can be inhibited by forced expression of constitutively active Cdc42Hs or Rac1. This supports the notion that at least in Balb/C and MEF cells, both Rac1 and Cdc42Hs activities are normally involved in survival signalling pathways. The anti-apoptotic signalling of the activated Rac, but not Cdc42Hs, has also been observed in apoptosis induced by constitutive Ras signalling (Joneson and Bar-Sagi, 1999) . On the other hand, previous reports have established that activation of distinct Rho family members can lead to similar phenotypes via a coordinated regulation of a cascade of activations. For example, sequential formation of polymerized actin structures has been described in microinjected serum-starved Swiss 3T3 cells, indicating that activation of Cdc42Hs stimulates the formation of microvilli and ®lopodia and activates Rac1, which in turn promotes the formation of lamellipodia and rues, and activates RhoA, which triggers stress ®bre assembly (Hall, 1998) . In other cases, hierarchical organization of Cdc42Hs and Rac1 signalling has not been observed (Roux et al., 1997) . We show that the inhibition of Rac1 and Cdc42Hs GTPases results in a similar eect on p53 activation, ERK-2 phosphorylation and apoptosis induction. However, these events appear to be triggered through distinct signalling pathways (data not shown).
Our data show that the loss of attachment to extracellular matrix or the loss of Cdc42Hs or Rac1 signalling in adherent ®broblasts kills cells in a manner which depends on functional p53. This ®nding constitutes a link between two major cellular signal transducing pathways. According to the cell type and the physiological context, the activation or overexpression of p53 has by itself been shown to promote apoptosis (reviewed in Hansen and Oren, 1997; Ko and Prives, 1996; Levine, 1997) . This is not the case in primary or immortalized ®broblasts, such as MEF and Balb/C 3T3, the cells we have used in the present study, where p53 activation signals cell cycle arrest, even though it can play a role of a co-factor in the induction of apoptosis (Lassus et al., 1996) . The requirement for p53 activity has been shown for the apoptosis induction by activated oncogenes (reviewed in Prives, 1998) . However, numerous signalling molecules induce apoptosis independently of p53 activity. Interestingly, unlike the situation reported here, the constitutively active form of Cdc42Hs (Cdc42HsV12) signals apoptosis in a p53 independent manner (Chuang et al., 1997) .
To determine whether p53 might be a downstream target of Cdc42Hs and Rac1, we examined the modulation of p53 activity upon GTPase inhibition. The dominant negative N17 forms of Rac1 and Cdc42Hs activated endogenous p53 and led to nuclear accumulation of one of its targets: the mdm2 oncogene. The mechanism of p53 activation by the mutant GTPases is unknown.
The activated GTP-bound forms of Rac1 and Cdc42Hs signal via the stress activated kinase pathways, with the activation of the JNK and p38 MAP kinases (Coso et al., 1995; Minden et al., 1994) . Our results demonstrate that the p38 activity is required for the protective eect of these GTPases on ®broblasts deprived of contacts with the extracellular matrix. Moreover, the activated forms of the GTPases, which do not give rise to signi®cant apoptosis by themselves, become strong inducers of death of adherent cells upon inhibition of p38, strengthening the argument that p38 signals survival in our experimental system. It is noteworthy that inhibition of p38 in control cells, where the Rho signalling pathways have not been perturbed, does not lead to apoptosis (Figure 6b ), indicating that p38 activity is not required for survival per se, but rather can participate in rescue of cells subjected to an apoptotic stimulus.
In parallel, we have shown that ERK activity is necessary for apoptosis induction both by loss of attachment and by expression of the N17 mutant Rac1 and Cdc42Hs GTPases. Indeed, the inhibition of MEK-1, an ERK-activating kinase, rescued the cells from apoptosis under both experimental conditions. Thus, our data establish that both p53 and ERK activity are required for apoptosis induction by Rac1N17 and Cdc42HsN17. Moreover, this apoptotic process is associated with an increase in p53 activity. It has been reported that ERK activation by the mos oncogene results in p53 activation, cell cycle arrest and apoptosis of mouse embryo ®broblasts (Fukasawa and Vande Woude, 1997) . Similarly, constitutively active Ras or Raf will induce both ERK and p53 in primary cells (Lloyd et al., 1997; Palmero et al., 1998; Serrano et al., 1997) . However, in our experimental system MAPK signalling is apparently not required for p53 activation, since both Rac1N17 and Cdc42HsN17 expression give rise to p53 activation even in the presence of the PD-098059 MEK1 inhibitor (data not shown).
In conclusion, our results show that inhibition of either Rac1 or Cdc42Hs in murine ®broblasts elicits a p53-and ERK-dependent apoptosis. While the crosstalk between p53 and ERK has previously been documented, our results represent the ®rst demonstration of a link between p53 and Rho family GTPases, two major cellular pathways involved in stress signalling.
Materials and methods

Plasmids
Human wild type p53 cDNA, and its mutated forms, H175 and H273 were cloned into the BamHI site of pCDNA3 vector (Invitrogen). Truncated rat CD2 antigen, kindly provided by Chris Norbury, lacks the intracytoplasmic domain and is expressed from the CMV promoter in the pKV461 vector. Constructs expressing MYC epitope-tagged mutant Rac1 and Cdc42Hs proteins (Dutartre et al., 1996) were kindly provided by P Chavrier. The GFP fusion proteins were cloned in the pEGFP-C1 vector (Clonetech). The HA-tagged p38 kinase expressing vector (pECE-HA-p38) was a kind gift of Anne Brunet. pCMV-WASP-GBD was constructed by the insertion of an EcoRI ± XhoI fragment of pGEX-KG-WASP (a kind gift of A Hall) into the same sites of pMYCS1. The WASP Cdc42-interacting domain spanning the amino-acids 201 ± 321 was cloned in frame with an upstream MYC tag located between the NcoI and EcoRI sites of pCDNA3.
Cell culture and transfections
Immortalized mouse embryonic Balb/C 3T3 cells express low levels of p53, whereas 10.1 cells are p53 7 , due to deletions in both p53 alleles (Harvey and Levine, 1991) . Primary mouse embryonic ®broblasts were used at early passages (4 ± 6). Cells were cultured in DMEM medium supplemented with 10% foetal calf serum in 5% CO 2 at 378C. Stable cell lines were obtained by infection with recombinant retroviral vectors, as previously described (Roux et al., 1997) . Transient transfections were performed on sub-con¯uent cells using the Lipofectamine method, as recommended by the supplier (Gibco ± BRL). Following transfection, cells were cultured for indicated times in medium supplemented with 10% foetal calf serum, after which¯oating and adherent cells were harvested, pooled and analysed. The toxicity due to the transfection typically did not exceed 5 ± 10% of the cells. For apoptosis assay, the transfected cells were identi®ed by labelling with anti-rat CD2 mAb OX-34 (Cedralane Laboratories). MAP kinase inhibitors SB203580 and PD-098059 were from Calbiochem and were used at 10 mM and 20 mM, respectively. Equivalent volumes of the vehicle (DMSO) were added to the control samples.
Where indicated, ®broblasts were put in suspension culture by plating cells (10 5 /ml) over 1% agarose (Gibco ± BRL) preequilibrated overnight with the culture medium.
Apoptosis assay
The¯ow cytometry assay for apoptosis was performed as previously described (Lassus and Hibner, 1998) . Brie¯y, 3610 5 ®broblasts were cotransfected on a 10 cm diameter dish with 6 mg total DNA containing 3 mg of appropriate mutant Rho GTPase plasmid, 2 mg of either WASP or vector alone and 1 mg of CD2 encoding plasmid, using lipofection (6 ml of Lipofectamine in 2.4 ml OptiMEM) during 4 h. Forty hours later, oating and adherent cells were collected, pooled and centrifuged. The pellets were taken up in Annexin V binding buer and incubated with Annexin-V-FLUOS (Boehringer Mannheim), as speci®ed by the manufacturer. The cells were then ®xed in 3.7% formaldehyde (Sigma), rinsed and incubated at room temperature for 2 h with biotinylated anti-rat CD2 antibody (mAB OX-34, Cedarlane), rinsed with PBS and incubated for 30 min with Streptavidin-Tri Color (Caltag). The quanti®cation of apoptosis in transfected cells population was determined by¯ow cytometry (Becton and Dickinson FacsScan) with FL-1 channel for Annexin-V-FLUOS and FL-3 channel for CD2-Tri Color.
Immunofluorescence
Cells were grown on coverslips and transfected with indicated GFP fusion proteins, pEGFP vector (negative control) or human wild type p53 cloned in pCDNA3 (positive control). Twenty-four hours post-transfection cells were ®xed in formaldehyde (3.7%), permeabilized with acetone and incubated either with anti-p53 polyclonal antibody (CM5, NovoCastra) or anti-mdm2 monoclonal antibody (2A10, a kind gift from Dr J Piette). Positive cells were revealed by incubation with biotin conjugated secondary antibody followed by labelling with streptavidin coupled to Texas Red¯uorochrome (Amersham).
